Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes

Abroad (travel likely)RecruitingPHASE4

Conditions

Diabetes Mellitus, Type 2 · Stroke (CVA) or Transient Ischemic Attack

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Washington - Harborview Medical Center, Seattle, Washington, United States

    Contact: Study coordinator (Francis Kim, MD) · fkim@u.washington.edu · 206-744-8305
    Contact: Principal Investigator (Francis Kim, MD)
Study leads
  • Francis Kim, MD

    Principal Investigator

    University of Washington